We are live on ! Find out more
ZVSA

ZyVersa Therapeutics
ZVSA

Delisted

ZVSA was delisted on the 16th of July, 2025.

Back to rankings

29 hedge funds and large institutions have $74.3M invested in ZyVersa Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

21% more funds holding

Funds holding: 24 → 29 (+5)

19% more capital invested

Capital invested by funds: $62.2M → $74.3M (+$12.1M)

0.04% more ownership

Funds ownership: 0.22% → 0.26% (+0.04%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
29
Holders Change
+5
Holders Change %
+20.83%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
YCM
Yakira Capital Management
Connecticut
+$5.52M
2
RCM
Rivernorth Capital Management
Florida
+$2.74M
3
CSS
Cubist Systematic Strategies
Connecticut
+$1.97M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$1.05M
5
OFG
OTA Financial Group
New York
+$290K

Top Sellers

1
WAM
Wolverine Asset Management
Illinois
-$31.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
26
BlackRock
New York
$50K – – –
AA
27
Ancora Advisors
Ohio
$20K – – –
EC
28
Elequin Capital
New York
$10K +$10.5K +3 New
CS
29
Clear Street
New York
$4K +$3.49K +1 New
1
2